1056189-12-8

Basic information

• Product Name: N-hydroxy-3-(trifluoromethyl)benzenecarboximidoyl chloride
• Synonyms: N-hydroxy-3-(trifluoromethyl)benzenecarboximidoyl chloride
• CAS NO: 1056189-12-8
• Molecular Weight: 223.582
• Mol File: 1056189-12-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-hydroxy-3-(trifluoromethyl)benzenecarboximidoyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: N-hydroxy-3-(trifluoromethyl)benzenecarboximidoyl chloride(1056189-12-8)
• EPA Substance Registry System: N-hydroxy-3-(trifluoromethyl)benzenecarboximidoyl chloride(1056189-12-8)

Safety Data

• Hazardous Substances Data: 1056189-12-8(Hazardous Substances Data)

Upstream product

• 154238-37-6 (E)-3-(trifluoromethyl)benzaldehyde oxime 

Downstream Products

• 708274-23-1 methyl 3-[3-(trifluoromethyl)phenyl]-4,5-dihydroisoxazole-5-carboxylate 

Relevant articles and documents

3-Cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

The present invention relates to 3-cycloalkylaminopyrrolidine derivatives of the formula I: (wherein R1, R2, R3, R4, R5, R6, R7, X, Y and Z are as defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of chemokine receptors and more specifically as modulators of the CCR2 and/or CCR5 receptor. The compounds and compositions of the invention may bind to chemokine receptors, e.g., the CCR2 and/or CCR5 chemokine receptors, and are useful for treating diseases associated with chemokine, e.g., CCR2 and/or CCR5, activity, such as atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis.